| EPAGE | p | ||
Inappropriate n (%) | Uncertain n (%) | Appropriate n (%) | ||
Age ≤ 50 years | 270 (44.3) | 150 (24.6) | 190 (31.1) | 0.0001 |
>50 years | 5 (1.5) | 5 (1.5) | 320 (97) | 0.0001 |
Sexe feminine | 165 (30.8) | 80 (15) | 290 (54.2) | 0.835 |
Male | 190 (40) | 55 (11.6) | 230 (48.4) | 0.835 |
Prescribers |
|
|
|
|
-General practitioner | 155 (32) | 75 (15.5) | 255 (56) | 0.693 |
-Gastroenterologist | 5 (12.5) | 10 (25) | 15 (62.5) | 0.529 |
Indications of the EGDF |
|
|
|
|
-Epigastralgia | 265 (36.3) | 145 (19.9) | 320 (43.8) | 0.0001 |
-Upper gastrointestinal bleeding | 00 (00.0) | 00 (00.0) | 95 (100) | 0.0001 |
-Pyrosis | 05 (11.1) | 00 (00.0) | 40 (88.9) | 0.095 |
-Vomiting | 00 (00.0) | 05 (14.3) | 30 (85.7) | 0.176 |
Insignificant endoscopic lesions | 215 (36.4) | 100 (16.9) | 275 (46.7) | 0.011 |
-Not erosive esophagitis | 10 (50) | 5 (25) | 5 (25) | 0.040 |
Significant lesions endoscopic | 55 (17.2) | 50 (15.6) | 215 (67.2) | 0.020 |
-Gastric and duodenal ulcer | 30 (17.6) | 20 (11.8) | 120 (70.6) | 0.105 |
-Esophageal varices | 00 (0.00) | 00 (0.00) | 10 (100) | 0.426 |
-Gastric polyp | 00 (0.00) | 5 (25) | 15 (75) | 0.013 |
-Gastric cancer | 00 (0.00) | 00 (0.00) | 10 (100) | 0.426 |
-Esophageal cancer | 00 (0.00) | 00 (0.00) | 10 (100) | 0.426 |